Vimarsana
Biggest News Aggregation in the World

Receptor Research News Today : Breaking News, Live Updates & Top Stories | Vimarsana

Stay updated with breaking news from Receptor Research. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.

Top News In Receptor Research Today - Breaking & Trending Today

CSPAN2 Congress July 2, 2024 - Vimarsana News

CSPAN2 Congress July 2, 2024

Americans also want to know why american ceos and executives continue t basic responsibility that theydeaths every day of the year in this country. And that was representative mike synar, a democrat of oklahoma. In 1994, at a highly publicized hearing on tobacco. And this week on our series. Congress investigates. Well, it was in april of 1994 that ceos Tobacco Companies went before congress as part of an investigation into Health Hazards posed by their products. Hour hearing was controversial. And it led to toopanies admitting their products were addictive. Industry followed. Joining us fhe t...

PainReform : NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON JUNE 1, 2023 - Form 6-K - Vimarsana News

PainReform : NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON JUNE 1, 2023 - Form 6-K

NOTICE OF ANNUAL GENERAL MEETING OF SHAREHOLDERS TO BE HELD ON JUNE 1, 2023 To the shareholders... | May 3, 2023

Research provides a comprehensive structural framework to design safer pain-relieving drugs - Vimarsana News

Research provides a comprehensive structural framework to design safer pain-relieving drugs

In the continuing effort to improve upon opioid pain relievers, American and Chinese scientists used cryoEM technology to solve the detailed structures of the entire family of opioid receptors bound to their naturally occurring peptides.

Algernon Highlights New Independent Research Review Identifying Ifenprodil as a Potential COVID-19 Treatment - Vimarsana News

Algernon Highlights New Independent Research Review Identifying Ifenprodil as a Potential COVID-19 Treatment

Algernon Highlights New Independent Research Review Identifying Ifenprodil as a Potential COVID-19 Treatment Algernon Pharmaceuticals Inc.  a clinical stage pharmaceutical development company, is pleased to highlight an independent research review published in the January 5 th edition of the European Archives of Psychiatry and Clinical Neuroscience that identified Ifenprodil as a possible re-purposed drug candidate for the treatment of COVID-19. The Review focuses on the sigma-1 receptor in the endoplasmic reticulum, a … Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AG...